Jennifer S Temel
Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
Temel, Jennifer S; Abernethy, Amy P; Currow, David C.; Friend, John; Duus, Elizabeth M; Yan, Ying; Fearon, Kenneth C
Authors
Amy P Abernethy
David C. Currow
John Friend
Elizabeth M Duus
Ying Yan
Kenneth C Fearon
Abstract
© 2016 Elsevier Ltd Background Patients with advanced cancer frequently experience anorexia and cachexia, which are associated with reduced food intake, altered body composition, and decreased functionality. We assessed anamorelin, a novel ghrelin-receptor agonist, on cachexia in patients with advanced non-small-cell lung cancer and cachexia. Methods ROMANA 1 and ROMANA 2 were randomised, double-blind, placebo-controlled phase 3 trials done at 93 sites in 19 countries. Patients with inoperable stage III or IV non-small-cell lung cancer and cachexia (defined as ≥5% weight loss within 6 months or body-mass index
Citation
Temel, J. S., Abernethy, A. P., Currow, D. C., Friend, J., Duus, E. M., Yan, Y., & Fearon, K. C. (2016). Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. The lancet oncology, 17(4), 519-531. https://doi.org/10.1016/S1470-2045%2815%2900558-6
Journal Article Type | Article |
---|---|
Online Publication Date | Feb 20, 2016 |
Publication Date | Apr 1, 2016 |
Deposit Date | Apr 9, 2019 |
Journal | The Lancet Oncology |
Print ISSN | 1470-2045 |
Electronic ISSN | 1474-5488 |
Publisher | Elsevier |
Peer Reviewed | Peer Reviewed |
Volume | 17 |
Issue | 4 |
Pages | 519-531 |
DOI | https://doi.org/10.1016/S1470-2045%2815%2900558-6 |
Public URL | https://hull-repository.worktribe.com/output/1563315 |
Publisher URL | https://www.sciencedirect.com/science/article/pii/S1470204515005586?via%3Dihub |
Additional Information | This article is maintained by: Elsevier; Article Title: Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials; Journal Title: The Lancet Oncology; CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S1470-2045(15)00558-6; CrossRef DOI link to the associated document: https://doi.org/10.1016/S1470-2045(16)00085-1; Content Type: article; Copyright: Copyright © 2016 Elsevier Ltd. All rights reserved. |
You might also like
Integration of oncology and palliative care: a Lancet Oncology Commission
(2018)
Journal Article
Breathlessness in the elderly during the last year of life sufficient to restrict activity
(2016)
Journal Article